Assessment of a Teachable Moment for Smoking Cessation

NCT ID: NCT00596440

Last Updated: 2015-08-28

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 234 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2007-08-31
• Study Completion Date: 2012-02-29

Brief Summary

A teachable moment (TM) refers to life events or transitions, such as physician visits, early detection screening feedback, pregnancy, and hospitalization for, and diagnosis of, disease, that inspire health behavior change. Despite strong intuitive appeal of the TM concept and over 150 studies of interventions implemented in a TM, there has been little investigation of the influence of TMs for smoking, particularly for promoting smoking cessation among those indirectly affected by a TM (e.g., relatives of cancer patients). This prospective observational study using a matched-group design will assess whether a lung cancer diagnosis increases enrollment in a smoking cessation program and cessation, and reduces smoking, among the patient's relatives/spouse who smoke. We will compare enrollment in a cessation program and cessation and smoking rates in 2 groups of smokers: 1) relatives/spouses of newly-diagnosed lung cancer patients, and 2) relatives/spouses of patients with an orthopedic condition. We will also explore mediators and moderators of a lung cancer diagnosis as a TM. This study could clarify the TM concept for smoking cessation, shed light on the underlying mechanisms of TMs, and guide future development and implementation of TM-based smoking cessation interventions.

Conditions

Nicotine Dependence

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: PROSPECTIVE

Study Groups

1

Relatives of Cancer Patients

Transdermal nicotine patch

Intervention Type: DRUG

8 weeks; 4 weeks of 21mg, 2 weeks of 14mg, and 2 weeks of 7mg.

2

Relatives of Orthopedic Patients

Transdermal nicotine patch

Intervention Type: DRUG

8 weeks; 4 weeks of 21mg, 2 weeks of 14mg, and 2 weeks of 7mg.

Interventions

Transdermal nicotine patch

8 weeks; 4 weeks of 21mg, 2 weeks of 14mg, and 2 weeks of 7mg.

Intervention Type: DRUG

Eligibility Criteria

Inclusion Criteria

1. A relative (i.e., sibling, parent, child, grandparent, aunt, uncle, cousin) or spouse of a newly-diagnosed lung or head and neck cancer patient or orthopedic patient (e.g., arthritis, bone and joint infection, foot and ankle conditions, hand, wrist, and elbow conditions such as carpal tunnel syndrome, shoulder and elbow conditions, such as rotator cuff injury, and knee conditions, such as ligament damage repair);

2. A regular smoker (i.e., smoke 10 cigarettes/day on average);

Exclusion Criteria

4. Age 18 or older (to use NRT); and

5. Living within ~50 miles of PENN (to allow for meetings at PENN).

1. Cannot communicate in English;

2. Have current alcohol abuse/dependence;

3. Are or have been diagnosed with cancer, asthma, HIV, emphysema, or COPD;

4. Have a current medical problem for which NRT is contraindicated such as uncontrolled hypertension (> 150 over 90), unstable angina, heart attack or stroke within the past 6 months, and liver and/or kidney failure in the last 6-months;

5. Currently use monoamine oxidase inhibitors or benzodiazepines, anti-psychotics, and antidepressants, including bupropion;

6. Are allergic to adhesive tape or latex, and

7. Are a female who is pregnant or nursing.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

National Institutes of Health (NIH)

NIH

Sponsor Role: collaborator

University of Pennsylvania

OTHER

Sponsor Role: lead

Responsible Party

Robert Schnoll

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Robert A Schnoll, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Countries

United States

Other Identifiers

NIH R01CA126969

Identifier Type: -

Identifier Source: secondary_id

805712

Identifier Type: -

Identifier Source: org_study_id